Deregulation of mTOR is often associated with cancer pathogenesis, and consistent with its inhibitory effect on mTOR activity, Deptor levels are frequently low in most of tumors with few exceptions such multiple myeloma (MM), thyroid carcinoma or lung cancer, where it is found to be highly expressed [1]. This evidence concerns the gene MTOR and AL amyloidosis.